• bitcoinBitcoin(BTC)$81,472.001.97%
  • Midas Fasanara Global EuroMidas Fasanara Global Euro(MGLOEURO)$111,813.00-0.36%
  • ethereumEthereum(ETH)$2,368.622.35%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$758.062.54%
  • rippleXRP(XRP)$1.332.13%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$102.922.84%
  • tronTRON(TRX)$0.3320251.42%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.00%
  • zcashZcash(ZEC)$1,313.044.91%
  • HyperliquidHyperliquid(HYPE)$81.985.43%
  • dogecoinDogecoin(DOGE)$0.0801693.81%
  • moneroMonero(XMR)$605.031.80%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$78.211.93%
  • chainlinkChainlink(LINK)$11.814.09%
  • leo-tokenLEO Token(LEO)$9.393.91%
  • cardanoCardano(ADA)$0.2074711.82%
  • nearNEAR Protocol(NEAR)$4.694.64%
  • stellarStellar(XLM)$0.1718212.21%
  • bitcoin-cashBitcoin Cash(BCH)$300.076.95%
  • RainRain(RAIN)$0.007052-0.37%
  • Ethena USDeEthena USDe(USDE)$1.000.04%
  • daiDai(DAI)$1.00-0.02%
  • litecoinLitecoin(LTC)$57.762.67%
  • uniswapUniswap(UNI)$7.171.94%
  • CantonCanton(CC)$0.1025156.45%
  • avalanche-2Avalanche(AVAX)$9.012.73%
  • USD1USD1(USD1)$1.000.02%
  • suiSui(SUI)$0.943.49%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.241.72%
  • hedera-hashgraphHedera(HBAR)$0.0765400.81%
  • tether-goldTether Gold(XAUT)$4,038.750.85%
  • Global DollarGlobal Dollar(USDG)$1.00-0.03%
  • paypal-usdPayPal USD(PYUSD)$1.000.02%
  • BittensorBittensor(TAO)$256.433.12%
  • shiba-inuShiba Inu(SHIB)$0.0000053.19%
  • quant-networkQuant(QNT)$200.65-2.09%
  • EthenaEthena(ENA)$0.2067551.94%
  • crypto-com-chainCronos(CRO)$0.0539902.89%
  • BitwayBitway(BTW)$1.7428.39%
  • Ripple USDRipple USD(RLUSD)$1.00-0.02%
  • MemeCoreMemeCore(M)$1.1111.10%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.06%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • okbOKB(OKB)$110.522.02%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$135.603.85%
  • pepePepe(PEPE)$0.00000515.51%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Ozempic maker overtook LVMH as Europe’s most valuable company

September 1, 2023
in Business
Reading Time: 9 mins read
A A
Ozempic maker overtook LVMH as Europe’s most valuable company
ShareShareShareShareShare

The pharma giant behind popular weight loss drugs Ozempic and Wegovy assumed the top spot as Europe’s most valuable company on Friday, overtaking French luxury empire LVMH, according to a report.

Novo Nordisk, the Danish multinational company, saw its market capitalization surge to $424.7 billion during Friday trading in London, beating out the luxury retail conglomerate owned by the family of Bernard Arnault.

YOU MAY ALSO LIKE

New York Knicks, Rangers officially split into separate publicly traded companies

The Orchard — Queens’ tallest building — is almost all leased out ahead of 2027 opening

LVMH, which has been Europe’s most valuable company for two-and-a-half years, had a market capitalization of $420.1 billion, according to Refinitiv data cited by the Reuters news agency.

Novo’s market capitalization also factored in unlisted shares that cannot be bought on any stock exchange.


Novo Nordisk, the Danish multinational company behind the popular drug Ozempic, saw its market capitalization surge on Friday.
REUTERS

In February 2021, LVMH, whose brands include Louis Vuitton, Dior, Sephora, and Dom Pérignon, dethroned Nestle, the Swiss food and drink conglomerate, to become Europe’s most valuable company.

Novo’s share price has roughly tripled in the past three years while LVMH’s has doubled.

The Danish firm’s shares have been up by some 17% since it announced last month that a large study had shown Wegovy also had a clear cardiovascular benefit, boosting the company’s hopes of moving beyond its image as a lifestyle drug.

Sales of Ozempic, a diabetes drug that doctors have been increasingly prescribing off-label to treat obesity as well as heart failure, have exploded, generating $3.2 billion in the second quarter — up from $2.1 billion in the same period last year.


Novo briefly assumed the top spot as Europe's most valuable company on Friday, overtaking French luxury empire LVMH, which is run by Bernard Arnault.
Novo briefly assumed the top spot as Europe’s most valuable company on Friday, overtaking French luxury empire LVMH, which is run by Bernard Arnault.
AFP via Getty Images

Wegovy and Saxenda, Novo drugs that have been approved to treat obesity, more than tripled their combined sales to $1.6 billion in the second quarter.

Other pharmaceutical players are looking to capitalize on the anti-obesity craze.

Eli Lilly’s diabetes drug Mounjaro generated $980 million in sales for the second quarter — up 72% from the first quarter of this year.

Lilly’s shareholders have seen a handsome return on their investment. In the last year, Lilly’s stock has soared by more than 80%.


LVMH, whose brands include Louis Vuitton, Dior, Sephora, and Dom Pérignon, has been Europe's most valuable company for the past two-and-a-half years.
LVMH, whose brands include Louis Vuitton, Dior, Sephora, and Dom Pérignon, has been Europe’s most valuable company for the past two-and-a-half years.
REUTERS

LVMH reported a drop in sales for the second quarter — an indication that spending on luxury retail goods among inflation-saddled Americans was on a downward keel.

Concerns about China’s weakening economy have also hurt investor sentiment towards LVMH.

Arnault and his family still boast the second-largest fortune in the world. They have a net worth valued by Bloomberg Billionaires Index at $186 billion.

With Post wires

Credit: Source link

ShareTweetSendSharePin

Related Posts

New York Knicks, Rangers officially split into separate publicly traded companies
Business

New York Knicks, Rangers officially split into separate publicly traded companies

October 27, 2026
The Orchard — Queens’ tallest building — is almost all leased out ahead of 2027 opening
Business

The Orchard — Queens’ tallest building — is almost all leased out ahead of 2027 opening

October 27, 2026
Ex-JPMorgan banker in ‘sex slave’ suit accused of getting sister to lie about kissing, racial remark: filing
Business

Ex-JPMorgan banker in ‘sex slave’ suit accused of getting sister to lie about kissing, racial remark: filing

October 27, 2026
White Bank of America exec claims he faced discrimination, was forced to resign while caring for ailing mom
Business

White Bank of America exec claims he faced discrimination, was forced to resign while caring for ailing mom

October 27, 2026
Next Post
GDP Rises, New Ford Mustang

GDP Rises, New Ford Mustang

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Alnylam: Amvuttra Growth And Brezosiran Strengthen The Bull Case

Alnylam: Amvuttra Growth And Brezosiran Strengthen The Bull Case

October 26, 2026
Zelenskyy meets with U.S. envoys in Norway, says intel sharing with U.S. ‘works now’

Zelenskyy meets with U.S. envoys in Norway, says intel sharing with U.S. ‘works now’

October 21, 2026
A Startup Called Warhound Is Genetically Engineering Dogs For The Military

A Startup Called Warhound Is Genetically Engineering Dogs For The Military

October 23, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!